Patent ID: 6319911
Filing Date: 2001-11-20
Classification: A61K,Y10S

Abstract:
A method of preventing ovarian cancer comprising administering to a female subject in need thereof a multiphase regimen comprising a first phase in which an estradiol estrogen product is administered in combination with a 19-nortestosterone progestin product; and a second phase in which an estradiol estrogen product is administered in combination with a 19-nortestosterone progestin product; and a third phase in which a 19-nortestosterone progestin product is not administered; and wherein said first phase is greater than 30 days and wherein the 19-nortestosterone progestin product administered in said second phase is characterized by at least twice the effective dosage of the 19-nortestosterone progestini product administered in said first phase, wherein the results obtained produce an enhanced effect.